Literature DB >> 28577626

Lung Cancer Screening.

Richard M Hoffman1, Rolando Sanchez2.   

Abstract

Lung cancer is the leading cause of cancer death in the United States. More than 80% of these deaths are attributed to tobacco use, and primary prevention can effectively reduce the cancer burden. The National Lung Screening Trial showed that low-dose computed tomography (LDCT) screening could reduce lung cancer mortality in high-risk patients by 20% compared with chest radiography. The US Preventive Services Task Force recommends annual LDCT screening for persons aged 55 to 80 years with a 30-pack-year smoking history, either currently smoking or having quit within 15 years. Published by Elsevier Inc.

Entities:  

Keywords:  Decision making; Early detection of cancer; Lung neoplasms; Practice guidelines; Tobacco use; Tomography, X-ray computed

Mesh：

Year:  2017        PMID： 28577626      PMCID： PMC7368999          DOI： 10.1016/j.mcna.2017.03.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  61 in total

1.  Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Authors:  Florian Kocher; Wolfgang Hilbe; Andreas Seeber; Andreas Pircher; Thomas Schmid; Richard Greil; Jutta Auberger; Meinhard Nevinny-Stickel; William Sterlacci; Alexandar Tzankov; Herbert Jamnig; Karin Kohler; August Zabernigg; Josef Frötscher; Wilhelm Oberaigner; Michael Fiegl
Journal:  Lung Cancer       Date:  2014-12-18       Impact factor: 5.705

2.  Estimating overdiagnosis in lung cancer screening--reply.

Authors:  Edward F Patz; Paul Pinsky; Barnett S Kramer
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

Review 3.  Benefits and harms of CT screening for lung cancer: a systematic review.

Authors:  Peter B Bach; Joshua N Mirkin; Thomas K Oliver; Christopher G Azzoli; Donald A Berry; Otis W Brawley; Tim Byers; Graham A Colditz; Michael K Gould; James R Jett; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Amir Qaseem; Frank C Detterbeck
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

4.  An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Authors:  Renda Soylemez Wiener; Michael K Gould; Douglas A Arenberg; David H Au; Kathleen Fennig; Carla R Lamb; Peter J Mazzone; David E Midthun; Maryann Napoli; David E Ost; Charles A Powell; M Patricia Rivera; Christopher G Slatore; Nichole T Tanner; Anil Vachani; Juan P Wisnivesky; Sue H Yoon
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Authors:  Nanda Horeweg; Joost van Rosmalen; Marjolein A Heuvelmans; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Ernst Th Scholten; Kevin ten Haaf; Kristiaan Nackaerts; Jan-Willem J Lammers; Carla Weenink; Harry J Groen; Peter van Ooijen; Pim A de Jong; Geertruida H de Bock; Willem Mali; Harry J de Koning; Matthijs Oudkerk
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

Review 7.  Combined pharmacotherapy and behavioural interventions for smoking cessation.

Authors:  Lindsay F Stead; Priya Koilpillai; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-03-24

8.  The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.

Authors:  Nichole T Tanner; Neeti M Kanodra; Mulugeta Gebregziabher; Elizabeth Payne; Chanita Hughes Halbert; Graham W Warren; Leonard E Egede; Gerard A Silvestri
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

9.  Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

Authors:  Harry J de Koning; Rafael Meza; Sylvia K Plevritis; Kevin ten Haaf; Vidit N Munshi; Jihyoun Jeon; Saadet Ayca Erdogan; Chung Yin Kong; Summer S Han; Joost van Rosmalen; Sung Eun Choi; Paul F Pinsky; Amy Berrington de Gonzalez; Christine D Berg; William C Black; Martin C Tammemägi; William D Hazelton; Eric J Feuer; Pamela M McMahon
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  Cancer mortality in the United States by education level and race.

Authors:  Jessica D Albano; Elizabeth Ward; Ahmedin Jemal; Robert Anderson; Vilma E Cokkinides; Taylor Murray; Jane Henley; Jonathan Liff; Michael J Thun
Journal:  J Natl Cancer Inst       Date:  2007-09-11       Impact factor: 13.506
View more
  31 in total

Review 1.  Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity.

Authors:  Lane Lerner; Robert Winn; Alicia Hulbert
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Computed tomography radiomic features hold prognostic utility for canine lung tumors: An analytical study.

Authors:  Hannah Able; Amber Wolf-Ringwall; Aaron Rendahl; Christopher P Ober; Davis M Seelig; Chris T Wilke; Jessica Lawrence
Journal:  PLoS One       Date:  2021-08-17       Impact factor: 3.240

3.  Using All Our Genomes: Blood-based Liquid Biopsies for the Early Detection of Cancer.

Authors:  Eddie Adams; Gregory D Sepich-Poore; Sandrine Miller-Montgomery; Rob Knight
Journal:  View (Beijing)       Date:  2022-01-31

4.  Role of chest radiographs in early lung cancer detection.

Authors:  Junghyun Kim; Kwan Hyoung Kim
Journal:  Transl Lung Cancer Res       Date:  2020-06

5.  An application of machine learning based on real-world data: Mining features of fibrinogen in clinical stages of lung cancer between sexes.

Authors:  Fangtao Yin; Hongyu Zhu; Songlin Hong; Chen Sun; Jie Wang; Mengting Sun; Lin Xu; Xiaoxiao Wang; Rong Yin
Journal:  Ann Transl Med       Date:  2021-04

6.  P16INK4a gene promoter methylation as a biomarker for the diagnosis of non-small cell lung cancer: An updated meta-analysis.

Authors:  Lei Tuo; Sha Sha; Zhang Huayu; Ke Du
Journal:  Thorac Cancer       Date:  2018-06-21       Impact factor: 3.500

7.  The Effect of Psychological Intervention on Nutrient Status of Perioperative Patients with Lung Cancer.

Authors:  Fen Xue; Fang Huang
Journal:  Iran J Public Health       Date:  2018-04       Impact factor: 1.429

8.  Correlations Between mRNA Levels of Centrosomal Protein 55 (CEP55) and Clinical Features of Patients with Lung Cancer.

Authors:  Xue-Ping Ma; Wenping Zhang; Bu-Qiang Wu; Jun Qin
Journal:  Med Sci Monit       Date:  2018-05-11

9.  Comparison of a 10-Year Cumulative Age-Standardized Incidence Rate of Lung Cancer among Metropolitan Cities in Korea (During the 2000⁻2009 Period): Review of Occupational and Environmental Hazards Associated with Lung Cancer.

Authors:  Joo Hyun Sung; Chang Sun Sim; Minsu Ock; Inbo Oh; Kyoung Sook Jeong; Cheolin Yoo
Journal:  Int J Environ Res Public Health       Date:  2018-06-13       Impact factor: 3.390

10.  Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.

Authors:  Yu Song; Han Cai; Tingjie Yin; Meirong Huo; Ping Ma; Jianping Zhou; Wenfang Lai
Journal:  Int J Nanomedicine       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.